Home > Quotes > SYN > Press Releases

Synthetic Biologics, Inc Press Releases

SYN 
$1.41
*  
0.01
  negative  
0.7%
Get SYN Alerts
*Delayed - data as of May 22, 2013 15:49 ET 
Exchange: AMEX
Industry: Consumer Durables
Community Rating:
View:    SYN After Hours
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
05/21/2013 7:00AM - PR Newswire

Synthetic Biologics Reports First Quarter 2013 Financial Results
05/15/2013 7:00AM - PR Newswire

Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
04/19/2013 7:00PM - PR Newswire

Synthetic Biologics Reports Year End 2012 Financial Results
04/16/2013 7:00AM - PR Newswire

Synthetic Biologics Announces Issuance of U.S. Patent Covering Combination of Estriol and Copaxone® for Multiple Sclerosis
04/04/2013 1:30PM - PR Newswire

Synthetic Biologics to Present at the 25th Annual ROTH Conference
03/12/2013 7:00AM - PR Newswire

Infectious Disease Specialist, Brad Spellberg, M.D., Joins Synthetic Biologics' Scientific Advisory Board
02/26/2013 7:00AM - PR Newswire

Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
02/22/2013 7:00AM - PR Newswire